Exos Asset Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Exos Asset Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$633K	Buy	64,138 +538	+0.8%	+$5.3K	0.33%	95
2022 Q1	$625K	Buy	63,600 +2,119	+3%	+$20.8K	0.27%	109
2021 Q4	$599K	Hold	61,481	–	–	0.31%	105
2021 Q3	$604K	Buy	61,481 +2,420	+4%	+$23.6K	0.32%	95
2021 Q2	$576K	Buy	59,061 +11,236	+23%	+$111K	0.3%	103
2021 Q1	$476K	Buy	+47,825	New	+$488K	0.37%	118

Other funds holding FLAC

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Exos Asset Management's FLAC Position: Q2 2022 in Review

Exos Asset Management increased its Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) stake by 0.85% in Q2 2022, buying an estimated $5.3K and bringing the position to 64,138 shares worth $633K. The position accounts for 0.33% of the portfolio, ranked #95.

Exos Asset Management first reported a position in FLAC in Q1 2021 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold FLAC as of Q2 2022.

Exos Asset Management held 64,138 shares of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares worth $633K as of Q2 2022.
Exos Asset Management bought 538 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q2 2022, an estimated $5.3K.
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares made up 0.33% of Exos Asset Management's portfolio in Q2 2022, its #95 holding.
Exos Asset Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and has held it in 6 quarters since.
50 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.